Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
US Department of Justice
Boehringer Ingelheim
Express Scripts

Generated: December 16, 2017

DrugPatentWatch Database Preview

Aurobindo Pharma Ltd Company Profile

« Back to Dashboard

What is the competitive landscape for AUROBINDO PHARMA LTD, and what generic and branded alternatives to AUROBINDO PHARMA LTD drugs are available?

AUROBINDO PHARMA LTD has two hundred and eighteen approved drugs.

There are twenty-eight tentative approvals on AUROBINDO PHARMA LTD drugs.

Summary for Aurobindo Pharma Ltd

US Patents:0
Drug Master File Entries: 224
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma LtdTRAMADOL HYDROCHLORIDEtramadol hydrochlorideTABLET, EXTENDED RELEASE;ORAL204421-003Oct 20, 2015AB1RXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma LtdGALANTAMINE HYDROBROMIDEgalantamine hydrobromideTABLET;ORAL090957-002Mar 29, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma LtdLOPERAMIDE HYDROCHLORIDEloperamide hydrochlorideTABLET;ORAL206548-001Dec 15, 2015OTCNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma LtdVANCOMYCIN HYDROCHLORIDEvancomycin hydrochlorideINJECTABLE;INJECTION205780-002Mar 31, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma LtdCLOZAPINEclozapineTABLET;ORAL206433-004Nov 29, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma LtdNAPROXENnaproxenTABLET;ORAL200429-002Nov 8, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma LtdPRAVASTATIN SODIUMpravastatin sodiumTABLET;ORAL203367-003Feb 2, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma LtdQUINAPRIL HYDROCHLORIDEquinapril hydrochlorideTABLET;ORAL202725-001Apr 29, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma LtdROPIVACAINE HYDROCHLORIDEropivacaine hydrochlorideSOLUTION;INJECTION205612-007Jul 13, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma LtdDIVALPROEX SODIUMdivalproex sodiumTABLET, EXTENDED RELEASE;ORAL202419-001Jun 2, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for AUROBINDO PHARMA LTD drugs

Drugname Dosage Strength Tradename Submissiondate
omeprazoleDelayed-release Tablets20 mgOMEPRAZOLE6/3/2015

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: